These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa]. Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203 [TBL] [Abstract][Full Text] [Related]
5. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view. Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146 [TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha for treatment of essential thrombocythemia during pregnancy: case report and review of the literature. Séror J; Sentilhes L; Lefebvre-Lacoeuille C; Marpeau L Fetal Diagn Ther; 2009; 25(1):136-40. PubMed ID: 19279390 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary sarcoidosis in a patient with essential thrombocythemia treated with interferon alpha: a short case report. Franková H; Gaja A; Hejlová N Med Sci Monit; 2000; 6(2):380-2. PubMed ID: 11208342 [TBL] [Abstract][Full Text] [Related]
8. [Adverse effects of interferon alfa]. Adam Z Vnitr Lek; 1994 Feb; 40(2):127-9. PubMed ID: 8140762 [TBL] [Abstract][Full Text] [Related]
9. Interferon alpha and its contribution to autoimmunity. Selmi C; Lleo A; Zuin M; Podda M; Rossaro L; Gershwin ME Curr Opin Investig Drugs; 2006 May; 7(5):451-6. PubMed ID: 16729722 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C. Demirturk N; Cevik F; Demirdal T; Aykin N; Aslan V Platelets; 2006 Aug; 17(5):340-3. PubMed ID: 16928608 [TBL] [Abstract][Full Text] [Related]
11. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection. Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary side effects of interferon-alpha therapy in patients with hematological malignancies. Anderson P; Höglund M; Rödjer S Am J Hematol; 2003 May; 73(1):54-8. PubMed ID: 12701122 [TBL] [Abstract][Full Text] [Related]
13. [Hypertriglyceridemia following treatment with interferon alpha in essential thrombocythemia]. De Salvo L; Plumacher Z; Gómez O; Weir-Medina J; Paz L; Salas D Invest Clin; 1996 Sep; 37(3):177-81. PubMed ID: 8983355 [TBL] [Abstract][Full Text] [Related]
15. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Mandac JC; Chaudhry S; Sherman KE; Tomer Y Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537 [TBL] [Abstract][Full Text] [Related]
16. Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy. Fritz M; Vats K; Goyal RK J Perinatol; 2005 Aug; 25(8):552-4. PubMed ID: 16047033 [TBL] [Abstract][Full Text] [Related]
17. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Boonyapisit K; Katirji B Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983 [TBL] [Abstract][Full Text] [Related]
18. Thyroid autoimmunity and dysfunction associated with type I interferon therapy. Monzani F; Caraccio N; Dardano A; Ferrannini E Clin Exp Med; 2004 Apr; 3(4):199-210. PubMed ID: 15103510 [TBL] [Abstract][Full Text] [Related]